Patrick Bauerle
7Patents
5h-index
23Co-inventors
59Inventor score
Filing activity: May 26, 2004 → Sep 19, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7635472B2 | Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders | Chemistry; Metallurgy | 87 | Expired |
| US8784821B1 | Human-anti-human cd3 binding molecules | Chemistry; Metallurgy | 56 | Active |
| US8076459B2 | Multispecfic deimmunized CD3-binders | Chemistry; Metallurgy | 49 | Active |
| US9102736B2 | Multispecific deimmunized CD3-binders | Chemistry; Metallurgy | 34 | Active |
| US8790645B2 | Pharmaceutical composition comprising a bispecific antibody for EpCAM | Emerging Cross-Sectional Technologies | 9 | Active |
| US10662243B2 | Dosage regimen for administering a CD19XCD3 bispecific antibody | Physics | 4 | Active |
| US7964707B2 | Anti-IL2 antibodies | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.